Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?

To: Andrew Vance who wrote (12645)	3/9/1998 1:09:00 PM
From: Proud_Infidel	Respond to of 17305

AV, re:it made good sense as to why UTEK should have prospered. unfortunately, the market hass yet to embrace it as it should. IMO, at least part of UTEK's failure to keep up w/ the likes of ASMLF is due to the fact that they have significant DD exposure. At this point in time, association w/ the DD sector in any way is the Kiss of Death. BK

To: Andrew Vance who wrote (12645)	3/13/1998 2:01:00 PM
From: Jeffrey S. Mitchell	Read Replies (1) \| Respond to of 17305

BTW-for those interested in a small morsel of information that I haven't fully ingested, Check out RIBI. Recall that they are seeking to be the first ever company to get approval for a cancer vaccine... The stock jumped 20% prior to an investor conference in Arizona on Saturday. Looks quiet today. Biotech is not my forte but it was worth mentioning. RIBI was at 5 on Monday. It's currently at 5.75 (another 15% gain). This stock will either make PLSIA's huge jump look like a blip, or watch out below if Canada doesn't approve the vaccine, for which a decision is supposed to come by the end of this month. Anyone feel lucky? Chart: tscn.com - Jeff